Get started
Author

Pietro Gigliotti

Observed names: P. Gigliotti, Pietro GIGLIOTTI
ORCID: 0000-0002-0806-4338
Observed ORCID: 0000-0002-0806-4338
OpenAlex ID: A5006617612
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series
2020 · Clodoveo Ferri, Dilia Giuggioli, et al. · Clinical Rheumatology · 146
PDF
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups
2021 · Clodoveo Ferri, Francesco Ursini, et al. · Journal of Autoimmunity · 121
PDF
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study
2021 · Clodoveo Ferri, Dilia Giuggioli, et al. · The Lancet Rheumatology · 35
PDF
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments
2021 · Clodoveo Ferri, Dilia Giuggioli, et al. · Current Pharmaceutical Design · 16
PDF
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP)
2018 · Caterina Palleria, Luigi Iannone, et al. · PLoS ONE · 11
PDF
Postoperative Autologous Reinfusion in Total Knee Replacement
2015 · A. Crescibene, F. Martire, et al. · Journal of Blood Transfusion · 11
PDF
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase
2023 · Clodoveo Ferri, Vincenzo Raimondo, et al. · Journal of Translational Autoimmunity · 10
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies
2022 · Clodoveo Ferri, Vincenzo Raimondo, et al. · Current Pharmaceutical Design · 9
Real-Life Use of Filgotinib in Rheumatoid Arthritis: A Retrospective Cohort Study
2024 · Vincenzo Raimondo, Maurizio Caminiti, et al. · Journal of Clinical Medicine · 6
PDF
Safety and effects of calcifediol 0.266 milligrams soft capsules monthly and cholecalciferol 25000 international units monthly in osteoporotic women undergoing therapy with alendronate: a cross-sectional study
2024 · Emiliano GIAMPÀ, Eleonora CELLETTI, et al. · Minerva Endocrinology · 3
Pos1267 Long-term Survey Study of the Impact of Covid-19 on Systemic Autoimmune Diseases. Low Death Rate Despite the Increased Prevalence of Symptomatic Infection. Role of Pre-existing Interstitial Lung Disease and Ongoing Treatments.
2022 · C. Ferri, V. Raimondo, et al. · Annals of the Rheumatic Diseases
PDF
Safety And Efficacy Of Calcifediol 0,266 Mg Soft Capsules Compared To Cholecalciferol In Osteoporotic Women Undergoing Therapy With Alendronate
2022 · Vincenzo Vinicola, Eleonora Celletti, et al. · Bone Reports
PDF
Pos1246 Covid-19 in Italian Patients With Rheumatic Autoimmune Systemic Diseases: Results of a Nationwide Survey Study
2021 · C. Ferri, D. Giuggioli, et al. · Annals of the Rheumatic Diseases
PDF
Works count: 13
Citation count: 368
H-index: 8
I10-index: 7
Year
Topic
Type